ABCL - Peter Thiel resigns from Abcellera board for personal reasons
2024-02-23 17:38:31 ET
More on AbCellera Biologics
- AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript
- AbCellera Biologics: Continuing To Expand Partnerships
- AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024
- AbCellera Biologics GAAP EPS of -$0.51 misses by $0.04, revenue of $38M misses by $0.13M
- Absci hits new 52-week high as race for AI drug discovery heats up